Gray Ghost Ventures

PayLatr is a recurring micro-credit mobile platform offering interest-free monthly credits to low-income households in India to easily pay for retail transactions without cash, credit cards or other pre-paid means. On average, a middle-income household in India spends about 7,000 – 9,000 rupees at any neighborhood store. More than 95 percent of transactions are in cash because most stores do not accept cards and/or users do not have credit cards. Often, households experience cash crunch issues by using up most of their cash for grocery shopping. PayLatr offers monthly credit to improve their household cash flow by providing recurring monthly credit lines at various merchants, via mobile money.

Atikus is dedicated to enhancing financial inclusion for micro, small, and medium enterprises (MSMEs) by offering innovative, technology-driven financial solutions. The company provides credit insurance, loans, and risk management services that cater specifically to the capital needs of underserved demographics, including women. By focusing on the unique challenges faced by these groups, Atikus aims to increase both the quantity and quality of financial products available, thereby empowering MSMEs to grow and develop. Through its targeted approach, the company works to strengthen the operational capabilities of lenders, ultimately fostering a more inclusive financial ecosystem that supports the future growth of the MSME sector.

D.light is a developer of solar home lighting and power products aimed at providing clean energy solutions to rural and semi-urban populations. The company offers a range of solar goods, including lights, radios, televisions, fans, and other home appliances, all powered by rechargeable solar kits. By making these products accessible and affordable, D.light seeks to improve health, increase productivity, and enhance the overall quality of life for its users.

Babajob Services is a technology-driven platform dedicated to connecting informal sector workers in India with employers. It specializes in matching job posts and job seekers based on proximity, price, and social connections, aiming to streamline the informal labor market by aggregating thousands of jobs and millions of job seekers. The company operates through its website and mobile portal, pushing matched connections via web, voice calls, SMS, and USSD.

PharmaSecure Inc. is a technology-driven company specializing in anti-counterfeiting and brand protection solutions for the pharmaceutical industry, with a global reach that includes operations in the United States and India. Founded in 2007, the company has developed a robust platform that provides regulatory serialization, market intelligence, and patient engagement solutions. Its services have enabled the coding of 2.5 billion drug packages across 300 packaging lines, serving prominent pharmaceutical companies and anti-malarial drug providers in various countries. Notably, PharmaSecure's SMS authentication technology allows consumers to verify the authenticity of medications through unique identifiers, thereby enhancing transparency in the supply chain. The company has earned recognition for its serialization capabilities, which help clients comply with stringent regulatory requirements in multiple countries. Additionally, through innovative patient engagement programs, PharmaSecure has successfully increased medication adherence rates by up to 60%, particularly in initiatives focused on tuberculosis patients in India.

LifeCity is a membership-based organization dedicated to fostering the growth of green businesses and promoting sustainable practices. It offers consulting services that focus on the development of eco-friendly enterprises, providing analysis and monitoring of various industries. LifeCity educates consumers about green products and services while training employees and communities on the benefits of sustainable business models. By encouraging the adoption of eco-friendly techniques, LifeCity aims to support both environmental and corporate development, enabling businesses to implement strategies that align with sustainability goals.

Kadmus Pharmaceuticals, Inc., a biopharmaceutical company, commercially exploits endocannabinoid pathways to develop therapeutics. Endocannabinoids are naturally occurring signaling molecules, whose functions include regulating mood, pain, and metabolism. It offers a portfolio of compounds with activity against a range of disorders targeting CNS conditions, metabolic disorders, neuropathic pain, and obesity. The company develops products for various conditions through the inhibition of endocannabinoid degradation and activation of endocannabinoid related pathways and peripheral cannabinoid receptors. It operates in the United States, Canada, and Europe. Kadmus Pharmaceuticals, Inc. was founded in 1998 and is based in Irvine, California.

Oxxon Therapeutics™ (Oxxon) is a company developing the next generation of innovative antigen-specific immunotherapies to treat patients with chronic infectious diseases and cancer. To date, the company has built an initial pipeline through its patented Hi-8™ PrimeBoost immunotherapy platform, an approach that allows the rapid development of products to selectively stimulate and enhance potent immune responses against disease. The company has successfully completed phase II clinical programmes in melanoma and hepatitis B and has a third development programme underway in HIV. In addition, the company intends to leverage its enabling platform through partnerships with companies developing therapeutic and preventative vaccine products.

Scion Pharmaceuticals is a biotechnology company that specializes in the research and development of small-molecule drugs. The company's primary focus is on identifying and optimizing treatments for central nervous system (CNS) disorders and cardiovascular diseases. Scion Pharmaceuticals is known for its innovative approach to drug development, particularly in the area of ion channel modulators, which play a crucial role in various physiological processes. Through its targeted research services, the company aims to advance therapeutic options and improve patient outcomes in these critical areas of healthcare.